Embecta (EMBC) Cash & Current Investments (2022 - 2026)
Embecta's (EMBC) quarterly Cash & Current Investments came in at $193.4 million in Q1 2026, down 8.9% year-on-year from $212.3 million in Q1 2025, and down 5.38% quarter-over-quarter from $204.4 million in Q4 2025.
Embecta (EMBC) Cash & Current Investments (2022 - 2026) Analysis & Trends
Embecta has disclosed Cash & Current Investments across 5 years of filings, most recently posting $193.4 million for Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $193.4 million, down 8.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $193.4 million (down 8.9% YoY), and the FY2025 annual result was $228.6 million, down 16.63% from the prior year.
- Cash & Current Investments came in at $193.4 million for Q1 2026 at Embecta, down from $204.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $385.2 million in Q4 2022 to a low of $193.4 million in Q1 2026.
- The 5-year median for Cash & Current Investments is $281.8 million (2024), against an average of $277.2 million.
- Across the five-year window, Cash & Current Investments surged 31.06% in 2023 and tumbled 30.73% in 2025, its largest moves.
- Embecta's Cash & Current Investments stood at $385.2 million in 2022, then slipped by 22.46% to $298.7 million in 2023, then retreated by 27.45% to $216.7 million in 2024, then fell by 5.68% to $204.4 million in 2025, then dropped by 5.38% to $193.4 million in 2026.
- The last three Cash & Current Investments figures came in at $193.4 million (Q1 2026), $204.4 million (Q4 2025), and $228.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 4.52 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 1.02 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 2.24 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 1.66 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 521.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.06 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 2.02 Bn |
| 10 | Embecta | 183.23 Mn | -10.17 Mn | 127.80 Mn | 193.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.40 Mn |
| Dec 31, 2025 | 204.40 Mn |
| Sep 30, 2025 | 228.60 Mn |
| Jun 30, 2025 | 233.60 Mn |
| Mar 31, 2025 | 212.30 Mn |
| Dec 31, 2024 | 216.70 Mn |
| Sep 30, 2024 | 274.20 Mn |
| Jun 30, 2024 | 281.80 Mn |
| Mar 31, 2024 | 306.50 Mn |
| Dec 31, 2023 | 298.70 Mn |
| Sep 30, 2023 | 326.50 Mn |
| Jun 30, 2023 | 317.40 Mn |
| Mar 31, 2023 | 346.40 Mn |
| Dec 31, 2022 | 385.20 Mn |
| Sep 30, 2022 | 330.90 Mn |
| Jun 30, 2022 | 292.30 Mn |
| Mar 31, 2022 | 264.30 Mn |